56 related articles for article (PubMed ID: 22001608)
1. Synthesis, characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats.
Bhandari KH; Newa M; Chapman J; Doschak MR
J Control Release; 2012 Feb; 158(1):44-52. PubMed ID: 22001608
[TBL] [Abstract][Full Text] [Related]
2. Response of trabecular bone, thyroid C and follicular cells to synthetic salmon calcitonin in middle-aged orchidectomized male rats.
Filipović B; Šošić-Jurjević B; Ajdžanović V; Živanović J; Ristić N; Trifunović S; Milošević V
J Anat; 2017 Jun; 230(6):787-795. PubMed ID: 28220476
[TBL] [Abstract][Full Text] [Related]
3. Advances in Controlled Drug Delivery for Treatment of Osteoporosis.
Asafo-Adjei TA; Chen AJ; Najarzadeh A; Puleo DA
Curr Osteoporos Rep; 2016 Oct; 14(5):226-38. PubMed ID: 27502334
[TBL] [Abstract][Full Text] [Related]
4. Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders.
Sawamoto K; Álvarez JV; Herreño AM; Otero-Espinar FJ; Couce ML; Alméciga-Díaz CJ; Tomatsu S
Curr Osteoporos Rep; 2020 Oct; 18(5):515-525. PubMed ID: 32845464
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate conjugation enhances the bone-specificity of NELL-1-based systemic therapy for spaceflight-induced bone loss in mice.
Ha P; Kwak JH; Zhang Y; Shi J; Tran L; Liu TP; Pan HC; Lee S; Kim JK; Chen E; Shirazi-Fard Y; Stodieck LS; Lin A; Zheng Z; Dong SN; Zhang X; Wu BM; Ting K; Soo C
NPJ Microgravity; 2023 Sep; 9(1):75. PubMed ID: 37723136
[TBL] [Abstract][Full Text] [Related]
6. Risedronate Effects on the In Vivo Bioactive Glass Behavior: Nuclear Magnetic Resonance and Histopathological Studies.
Mosbahi S; Oudadesse H; Roiland C; Lefeuvre B; Slimani L; Keskes H
Biomed Res Int; 2019; 2019():2175731. PubMed ID: 31915685
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of anti-osteoporosis therapy: Bisphosphonate-modified nanosystems and composites.
Shi S; Duan H; Ou X
Biomed Pharmacother; 2024 Jun; 175():116699. PubMed ID: 38705129
[TBL] [Abstract][Full Text] [Related]
8. Bioactivity and circulation time of PEGylated NELL-1 in mice and the potential for osteoporosis therapy.
Zhang Y; Velasco O; Zhang X; Ting K; Soo C; Wu BM
Biomaterials; 2014 Aug; 35(24):6614-21. PubMed ID: 24818884
[TBL] [Abstract][Full Text] [Related]
9. Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue.
Andreotti G; Vitale RM; Avidan-Shpalter C; Amodeo P; Gazit E; Motta A
J Biol Chem; 2011 Jan; 286(4):2707-18. PubMed ID: 21078667
[TBL] [Abstract][Full Text] [Related]
10. A Simplified Method for Determining Blood-to-Plasma Ratios
Zhang X; Jenkins GJ; Desino KE; Liu J; Larsen M; Stresser DM
Drug Metab Bioanal Lett; 2023; 16(2):113-120. PubMed ID: 37592774
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin inhibits SDCP-induced osteoclast apoptosis and increases its efficacy in a rat model of osteoporosis.
Kuo YJ; Tsuang FY; Sun JS; Lin CH; Chen CH; Li JY; Huang YC; Chen WY; Yeh CB; Shyu JF
PLoS One; 2012; 7(7):e40272. PubMed ID: 22792258
[TBL] [Abstract][Full Text] [Related]
12. Optimizing Delivery of Therapeutic Growth Factors for Bone and Cartilage Regeneration.
Takematsu E; Murphy M; Hou S; Steininger H; Alam A; Ambrosi TH; Chan CKF
Gels; 2023 May; 9(5):. PubMed ID: 37232969
[TBL] [Abstract][Full Text] [Related]
13. Bone-Targeted Delivery of Novokinin as an Alternative Treatment Option for Rheumatoid Arthritis.
Ranjit A; Khajeh Pour S; Aghazadeh-Habashi A
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015308
[TBL] [Abstract][Full Text] [Related]
14. Bone-targeted delivery of simvastatin-loaded PEG-PLGA micelles conjugated with tetracycline for osteoporosis treatment.
Xie Y; Liu C; Huang H; Huang J; Deng A; Zou P; Tan X
Drug Deliv Transl Res; 2018 Oct; 8(5):1090-1102. PubMed ID: 30027372
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate conjugation for bone specific drug targeting.
Farrell KB; Karpeisky A; Thamm DH; Zinnen S
Bone Rep; 2018 Dec; 9():47-60. PubMed ID: 29992180
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled filomicelles prepared from polylactide-poly(ethylene glycol) diblock copolymers for sustained delivery of cycloprotoberberine derivatives.
Liu X; Wang Y; Yun P; Shen X; Su F; Chen Y; Li S; Song D
Saudi Pharm J; 2018 Mar; 26(3):342-348. PubMed ID: 29556125
[TBL] [Abstract][Full Text] [Related]
17. Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats.
Yang Y; Aghazadeh-Habashi A; Panahifar A; Wu Y; Bhandari KH; Doschak MR
Drug Deliv Transl Res; 2017 Aug; 7(4):482-496. PubMed ID: 28721611
[TBL] [Abstract][Full Text] [Related]
18. A Drug Carrier for Sustained Zero-Order Release of Peptide Therapeutics.
Zhao YN; Xu X; Wen N; Song R; Meng Q; Guan Y; Cheng S; Cao D; Dong Y; Qie J; Liu K; Zhang Y
Sci Rep; 2017 Jul; 7(1):5524. PubMed ID: 28717204
[TBL] [Abstract][Full Text] [Related]
19. Bone-seeking agents for the treatment of bone disorders.
Cawthray J; Wasan E; Wasan K
Drug Deliv Transl Res; 2017 Aug; 7(4):466-481. PubMed ID: 28589453
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
